Wandercraft

Wandercraft

Wandercraft is the French robotics company building AI-powered self-balancing exoskeletons for paraplegic patients, hospital rehabilitation, and (eventually) general consumer mobility. Wandercraft's Atalante X exoskeleton received FDA clearance in 2024 as the first personal self-balancing exoskeleton — meaning users walk in it without crutches or external balance support. Wandercraft has raised approximately $130M+ across rounds led by Bpifrance and Quadrille Capital with Lightspeed participation.

Production credibility: Approximately $130M+ raised across rounds led by Bpifrance and Quadrille Capital with Lightspeed Venture Partners participating. Founded 2012 by Nicolas Simon, Matthieu Masselin, Alexandre Boulanger, and Jean-Louis Constanza. Atalante X received FDA clearance in 2024 as the first personal self-balancing exoskeleton. Used in 90+ hospital rehabilitation centers globally. Paris HQ with US operations.

Key Features

• Atalante X — AI-powered self-balancing personal exoskeleton (FDA-cleared 2024)
• First exoskeleton allowing paraplegic users to walk without crutches or external balance support
• Used in 90+ hospital rehabilitation centers globally
• Founded 2012 in Paris by Nicolas Simon, Matthieu Masselin, Alexandre Boulanger, Jean-Louis Constanza
• $130M+ raised; Bpifrance + Quadrille Capital lead with Lightspeed Venture Partners
• Paris HQ with US operations expanding for the FDA-cleared personal market
• Onboard AI continuously rebalances and adapts gait to terrain and user weight shifts

Ideal Use Case

Paraplegic users seeking restored walking ability, hospital rehabilitation centers providing gait therapy for stroke and spinal-cord-injury patients, and (longer-term) consumers needing mobility assistance.

How Wandercraft differentiates

Ekso Bionics and ReWalk Robotics were earlier exoskeleton players but their devices require crutches or external balance support — limiting daily-life usability. Wandercraft's differentiator is the AI-powered self-balancing — the onboard control system continuously rebalances the user, eliminating the need for crutches. FDA clearance of Atalante X in 2024 made Wandercraft the first personal self-balancing exoskeleton on the US market. The trade-off is the price ($150K+ for personal use) and the still-limited adoption beyond rehabilitation centers; the upside is a category-defining technical lead in self-balancing locomotion.

FAQ

Q: What is Wandercraft? A: Wandercraft is a French robotics company building AI-powered self-balancing exoskeletons for paraplegic patients, hospital rehabilitation, and consumer mobility. Atalante X was FDA-cleared in 2024.

Q: Who founded Wandercraft? A: Nicolas Simon, Matthieu Masselin, Alexandre Boulanger, and Jean-Louis Constanza co-founded Wandercraft in 2012 in Paris.

Q: How much has Wandercraft raised? A: Approximately $130M+ across rounds led by Bpifrance and Quadrille Capital with Lightspeed Venture Partners participating.

Q: Wandercraft vs Ekso Bionics vs ReWalk? A: Ekso Bionics and ReWalk Robotics were earlier exoskeleton players but their devices require crutches or external balance support. Wandercraft's Atalante X self-balances via onboard AI — the first personal exoskeleton allowing users to walk without crutches, FDA-cleared 2024.

Q: How much does the Atalante X cost? A: Atalante X is priced around $150K+ for personal use. Hospital rehabilitation deployments use different pricing models. Insurance coverage varies by jurisdiction.

tl;dr

Wandercraft is the French robotics company behind Atalante X — the FDA-cleared (2024) AI-powered self-balancing personal exoskeleton. $130M+ raised; Bpifrance + Quadrille + Lightspeed. Founded 2012 in Paris. First exoskeleton letting paraplegic users walk without crutches. 90+ hospital rehabilitation deployments globally.

Related

Looking for more options? Browse the AI/ML Models directory or read our best AI models listicle. Wandercraft is also tracked on Crunchbase.